# FDA Inspection 1279096 - Spera Nexus, Inc. - July 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/spera-nexus-inc/8abcc462-47ab-4541-ab1a-6709c0c71bbc
Source feed: FDA_Inspections

> FDA Inspection 1279096 for Spera Nexus, Inc. on July 10, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279096
- Company Name: Spera Nexus, Inc.
- Inspection Date: 2025-07-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1279096 - 2025-07-10](https://www.keypedia.com/records/fda_inspections/spera-nexus-inc/173185be-234c-4247-aa21-9e780632c457)
- [FDA Inspection 1111915 - 2019-11-01](https://www.keypedia.com/records/fda_inspections/spera-nexus-inc/cf0e0cf1-953f-4430-8b58-8f4b5794aa3e)
- [FDA Inspection 912550 - 2015-01-16](https://www.keypedia.com/records/fda_inspections/spera-nexus-inc/1e179889-4b21-43b4-8c7d-ad3ae00defa0)
- [FDA Inspection 781863 - 2012-04-19](https://www.keypedia.com/records/fda_inspections/spera-nexus-inc/8ed2c19b-4299-4fd5-9dff-c0e4b2073876)

Company: https://www.keypedia.com/companies/spera-nexus-inc/754f996b-f27d-489e-bcf8-cbc4ca161f49

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c